Yüklüyor......

Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette–Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer

A significant number of patients with intermediate- or high-risk bladder cancer treated with intravesical Bacillus Calmette–Guérin (BCG) immunotherapy are non-responders to this treatment. Since we cannot predict in which patients BCG therapy will fail, markers for responders are needed. UroVysion(®...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Med Oncol
Asıl Yazarlar: Liem, Esmee I. M. L., Baard, Joyce, Cauberg, Evelyne C. C., Bus, Mieke T. J., de Bruin, D. Martijn, Laguna Pes, M. Pilar, de la Rosette, Jean J. M. C. H., de Reijke, Theo M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer US 2017
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581817/
https://ncbi.nlm.nih.gov/pubmed/28866819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-017-1033-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!